| Study | Type of data | Exposure measurement | Outcome assessment | Adjustment |
|---|---|---|---|---|
| Ozturk, 2016 | prospective cohort | At the first contact, initiated via gynecologists, a detailed patient history form was used to notably record all drug exposures (dose, duration and timing in pregnancy). | Each newborn baby was checked at birth for signs of problems or complications. | None |
| Yaris, 2005 | prospective cohort | Data surveyed by the interviews. | Examinations were made by obstetric ultrasound for the mothers and birth weight and height, gestational age, APGAR scores, congenital malformation and developmental problems for the babies. Periodic checks of all the babies in the neonatal period, were made the first year, and following years. | None for this group of exposure. |